Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.
S. Jangra, A. Lamoot, G. Singh, G. Laghlali, Y. Chen, T. Ye, A. Garcia-Sastre, B. G. De Geest, M. Schotsaert
This study evaluates how lipid nanoparticle (LNP) composition and adjuvant combinations affect immune responses and protection in mice vaccinated against influenza.
bioRxiv · Jan 14, 2024 · PreprintMicrobiology